113 related articles for article (PubMed ID: 8490922)
1. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines.
Angioli R; Sevin BU; Perras JP; Untch M; Koechli OR; Nguyen HN; Steren A; Schwade JG; Villani C; Averette HE
Cancer; 1993 Jun; 71(11):3717-25. PubMed ID: 8490922
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitizing effect of natural and recombinant beta-interferons in a human lung carcinoma in vitro.
Schmidberger H; Rave-Fränk M; Lehmann J; Schweinfurth S; Pradier O; Hess CF
J Cancer Res Clin Oncol; 1999; 125(6):350-6. PubMed ID: 10363567
[TBL] [Abstract][Full Text] [Related]
4. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel: a radiation sensitizer of human cervical cancer cells.
Rodriguez M; Sevin BU; Perras J; Nguyen HN; Pham C; Steren AJ; Koechli OR; Averette HE
Gynecol Oncol; 1995 May; 57(2):165-9. PubMed ID: 7729728
[TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
[TBL] [Abstract][Full Text] [Related]
7. Effects of radiation on TNF alpha-mediated cytolysis of cell lines derived from cervical carcinomas.
Herzog TJ; Nelson PK; Mutch DG; Wright WD; Kao MS; Collins JL
Gynecol Oncol; 1992 Nov; 47(2):196-202. PubMed ID: 1468697
[TBL] [Abstract][Full Text] [Related]
8. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha.
Hoffmann W; Bläse MA; Santo-Hoeltje L; Herskind C; Bamberg M; Rodemann HP
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):991-8. PubMed ID: 10571207
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
[TBL] [Abstract][Full Text] [Related]
10. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
[TBL] [Abstract][Full Text] [Related]
11. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
12. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
[TBL] [Abstract][Full Text] [Related]
14. The combined effect of interferon beta and radiation on five human tumor cell lines and embryonal lung fibroblasts.
Schmidberger H; Rave-Fränk M; Lehmann J; Schweinfurth S; Rehring E; Henckel K; Hess CF
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):405-12. PubMed ID: 10030269
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
16. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
17. Application of the ATP-cell viability assay for assessment of biologic response modifiers in gynecologic cancer.
Angioli R; Sevin BU
Contrib Gynecol Obstet; 1994; 19():166-78. PubMed ID: 7995048
[No Abstract] [Full Text] [Related]
18. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle.
Chang AY; Keng PC
Cancer Res; 1987 Aug; 47(16):4338-41. PubMed ID: 2440565
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer.
Byhardt RW; Vaickus L; Witt PL; Chang AY; McAuliffe T; Wilson JF; Lawton CA; Breitmeyer J; Alger ME; Borden EC
J Interferon Cytokine Res; 1996 Nov; 16(11):891-902. PubMed ID: 8938564
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation of lines derived from human cervical carcinomas by cytotoxic drugs and by recombinant interferons.
Jacobs AJ; Dawoud L; Kovacs Z; Ratliff TL
Gynecol Oncol; 1989 Jan; 32(1):31-6. PubMed ID: 2491828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
